Malgorzata A. Walicka

Array ( [id] => 5527859 [patent_doc_number] => 20090197936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'SALTS OF N-HYDROXY-3-[4-[[[2-(2-METHYL-1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-2E-2-PROPENAMIDE' [patent_app_type] => utility [patent_app_number] => 12/302571 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16983 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197936.pdf [firstpage_image] =>[orig_patent_app_number] => 12302571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485855 [patent_doc_number] => 20090275620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'SUBSTITUTED 5- PHENYLAMINO- 1, 3, 4-OXADIAZOL-2-YLCARBONYLAMINO-4-PHENOXY-CYCLOHEXANE CARBOXYLIC ACID AS INHIBITORS OF ACETYL COENZYME A DIACYLGLYCEROL ACYLTRANSFERASE' [patent_app_type] => utility [patent_app_number] => 12/302185 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11703 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275620.pdf [firstpage_image] =>[orig_patent_app_number] => 12302185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424542 [patent_doc_number] => 20100151351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => ' MONOMERS AND POLYMERS CARRYING IMIDAZOLE AND BENZIMIDAZOLE GROUPINGS, AND PROTON EXCHANGE MEMBRANE CONTAINING THE SAME FOR THE PRODUCTION OF A FUEL CELL' [patent_app_type] => utility [patent_app_number] => 12/303722 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5976 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151351.pdf [firstpage_image] =>[orig_patent_app_number] => 12303722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4827329 [patent_doc_number] => 20080125587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Synthesis of triazole compounds that modulate HSP90 activity' [patent_app_type] => utility [patent_app_number] => 11/807333 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41617 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125587.pdf [firstpage_image] =>[orig_patent_app_number] => 11807333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83869 [patent_doc_number] => 07741360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Bi-aryl or aryl-heteroaryl substituted indoles' [patent_app_type] => utility [patent_app_number] => 12/302353 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7786 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741360.pdf [firstpage_image] =>[orig_patent_app_number] => 12302353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4535328 [patent_doc_number] => 07872145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Aziridinyl-epothilone compounds' [patent_app_type] => utility [patent_app_number] => 11/753785 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 21320 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872145.pdf [firstpage_image] =>[orig_patent_app_number] => 11753785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909470 [patent_doc_number] => 08481535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor' [patent_app_type] => utility [patent_app_number] => 12/301212 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23466 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12301212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374755 [patent_doc_number] => 20090312316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/296482 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12635 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312316.pdf [firstpage_image] =>[orig_patent_app_number] => 12296482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5423016 [patent_doc_number] => 20090149471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Monocyclic Heterocyclic Compounds' [patent_app_type] => utility [patent_app_number] => 12/227130 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25434 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149471.pdf [firstpage_image] =>[orig_patent_app_number] => 12227130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687300 [patent_doc_number] => 20090176991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'BENZAMIDE GLUCOKINASE ACTIVATORS' [patent_app_type] => utility [patent_app_number] => 12/298852 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29276 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176991.pdf [firstpage_image] =>[orig_patent_app_number] => 12298852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410711 [patent_doc_number] => 20090124610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'PHARMACEUTICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/298384 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41034 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124610.pdf [firstpage_image] =>[orig_patent_app_number] => 12298384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146757 [patent_doc_number] => 08163746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Azolecarboxamide derivative' [patent_app_type] => utility [patent_app_number] => 12/297275 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48404 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163746.pdf [firstpage_image] =>[orig_patent_app_number] => 12297275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546831 [patent_doc_number] => 20100016379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Terephthalamate Compounds and Compositions, and Their Use as HIV Integrase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/300171 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21678 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016379.pdf [firstpage_image] =>[orig_patent_app_number] => 12300171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113711 [patent_doc_number] => 20070197627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Indoline compound and process for producting the same' [patent_app_type] => utility [patent_app_number] => 11/787312 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3485 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197627.pdf [firstpage_image] =>[orig_patent_app_number] => 11787312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485816 [patent_doc_number] => 20090275581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'RENIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/225987 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112578 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275581.pdf [firstpage_image] =>[orig_patent_app_number] => 12225987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496404 [patent_doc_number] => 20090264432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Piperidine and Morpholine Renin Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/225986 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54239 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264432.pdf [firstpage_image] =>[orig_patent_app_number] => 12225986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247891 [patent_doc_number] => 20070244125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => '5-amido-indole-2-carboxamide derivatives' [patent_app_type] => utility [patent_app_number] => 11/784041 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43627 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244125.pdf [firstpage_image] =>[orig_patent_app_number] => 11784041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436327 [patent_doc_number] => 20090170914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Cermide Kinase Modulation' [patent_app_type] => utility [patent_app_number] => 12/295375 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15840 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170914.pdf [firstpage_image] =>[orig_patent_app_number] => 12295375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515721 [patent_doc_number] => 20090216028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer' [patent_app_type] => utility [patent_app_number] => 11/991406 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25415 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20090216028.pdf [firstpage_image] =>[orig_patent_app_number] => 11991406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296313 [patent_doc_number] => 20100240622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'NITRIC OXIDE ENHANCING PROSTAGLANDIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/294642 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24130 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240622.pdf [firstpage_image] =>[orig_patent_app_number] => 12294642 [rel_patent_id] =>[rel_patent_doc_number] =>)